Table 1. Characteristics of the study patients (n = 50).
Subset | No. of patients (%) | |
---|---|---|
[Median (range) age in years | 67 (44–78)] | |
Sex | Male | 45 (90) |
Female | 5 (10) | |
Smoking status | Never | 3 (6) |
Smoker | 47 (94) | |
ECOG performance status | 0–1 | 46 (92) |
2–3 | 4 (8) | |
Tumor histology | Squamous cell carcinoma | 48 (96) |
Adenocarcinoma | 2 (4) | |
Tumor location | Cervical | 3 (6) |
Upper thoracic | 12 (24) | |
Middle thoracic | 20 (40) | |
Lower thoracic | 14 (28) | |
Abdominal | 1 (2) | |
T stage | T1 | 0 (0) |
T2 | 1 (2) | |
T3 | 32 (64) | |
T4a/T4b | 3 (6)/14 (28) | |
N stage | N0 | 1 (2) |
N1 | 28 (56) | |
N2 | 8 (16) | |
N3 | 13 (26) | |
Metastasis sites | Lymph nodes | 40 |
Liver | 19 | |
Lung | 19 | |
Bone | 13 | |
Adrenal gland | 3 | |
Kidney | 1 | |
Peritoneum | 1 | |
Pleura | 2 | |
[Median (range) tumor length (cm) | 6 (3–20)] | |
Dysphagia score | 0 (asymptomatic) | 1 (2) |
1 (eat solid diet with some dysphagia) | 9 (18) | |
2 (eat semisolid diet) | 28 (56) | |
3 (drink liquid diet) | 8 (16) | |
4 (complete dysphagia) | 4 (8) | |
Chemotherapy regimen | 5-FU + cisplatin | 43 (86) |
5-FU + nedaplatin | 6 (12) | |
5-FU alone | 1 (2) | |
Total radiation dose (Gy) | 54 | 2 (4) |
50 | 43 (86) | |
< 50 | 5 (10) |